| Product Code: ETC9975894 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Seasonal Influenza Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Seasonal Influenza Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Seasonal Influenza Market - Industry Life Cycle |
3.4 United States (US) Seasonal Influenza Market - Porter's Five Forces |
3.5 United States (US) Seasonal Influenza Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Seasonal Influenza Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Seasonal Influenza Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Seasonal Influenza Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Seasonal Influenza Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Seasonal Influenza Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and emphasis on preventive healthcare measures |
4.2.2 Growing elderly population in the US, who are more susceptible to influenza |
4.2.3 Innovation in vaccine technology leading to more effective and accessible vaccines |
4.3 Market Restraints |
4.3.1 Seasonal variations in the influenza virus strains, leading to challenges in vaccine effectiveness |
4.3.2 Vaccine hesitancy and misinformation impacting vaccination rates |
4.3.3 Limited access to healthcare services in certain demographics or regions |
5 United States (US) Seasonal Influenza Market Trends |
6 United States (US) Seasonal Influenza Market, By Types |
6.1 United States (US) Seasonal Influenza Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Seasonal Influenza Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Seasonal Influenza Market Revenues & Volume, By Influenza A Viruses, 2021- 2031F |
6.1.4 United States (US) Seasonal Influenza Market Revenues & Volume, By Influenza B Viruses, 2021- 2031F |
6.1.5 United States (US) Seasonal Influenza Market Revenues & Volume, By Influenza C Virus, 2021- 2031F |
6.1.6 United States (US) Seasonal Influenza Market Revenues & Volume, By Influenza D Viruses, 2021- 2031F |
6.1.7 United States (US) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Seasonal Influenza Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Seasonal Influenza Market Revenues & Volume, By Antiviral, 2021- 2031F |
6.2.3 United States (US) Seasonal Influenza Market Revenues & Volume, By Neuraminidase Inhibitors, 2021- 2031F |
6.2.4 United States (US) Seasonal Influenza Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.5 United States (US) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Seasonal Influenza Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Seasonal Influenza Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Seasonal Influenza Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United States (US) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Seasonal Influenza Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Seasonal Influenza Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Seasonal Influenza Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Seasonal Influenza Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United States (US) Seasonal Influenza Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Seasonal Influenza Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Seasonal Influenza Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Seasonal Influenza Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Seasonal Influenza Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Seasonal Influenza Market Import-Export Trade Statistics |
7.1 United States (US) Seasonal Influenza Market Export to Major Countries |
7.2 United States (US) Seasonal Influenza Market Imports from Major Countries |
8 United States (US) Seasonal Influenza Market Key Performance Indicators |
8.1 Percentage of population vaccinated against seasonal influenza |
8.2 Number of reported influenza cases in high-risk populations |
8.3 Research and development investment in new vaccine technologies |
8.4 Public health campaigns' reach and effectiveness |
8.5 Adoption rates of telemedicine and remote healthcare services for influenza consultations |
9 United States (US) Seasonal Influenza Market - Opportunity Assessment |
9.1 United States (US) Seasonal Influenza Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Seasonal Influenza Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Seasonal Influenza Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Seasonal Influenza Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Seasonal Influenza Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Seasonal Influenza Market - Competitive Landscape |
10.1 United States (US) Seasonal Influenza Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Seasonal Influenza Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here